# Biktarvy in Treatment-Naïve Late Presenters With HIV-1 Infection

> **NCT04296695** · PHASE4 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 250 (estimated)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** B/F/TAF
- **DRUG:** TDF/3TC/EFV

## Key facts

- **NCT ID:** NCT04296695
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-14
- **Primary completion:** 2022-12-13
- **Final completion:** 2023-12-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2023-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04296695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04296695, "Biktarvy in Treatment-Naïve Late Presenters With HIV-1 Infection". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT04296695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
